Clinical Course and Management of Iatrogenic Cushing's Syndrome after Co-Administration of Injected-Triamcinolone and Ritonavir: a Systematic Review

Gregor John^1*, Diana Ollo¹, Patrick Meyer¹, Markus Herold², Caroline Flora Samer³ and Alexandra Calmy⁴

¹Department of Internal Medicine Specialties, Geneva University Hospitals (HUG), Switzerland, E-mail: diano.ollo@gmail.com

²Private medical practice for infectious diseases, Maihofstrasse 1, Switzerland, E-mail: diano.ollo@gmail.com

³Department of Clinical Pharmacology and Toxicology, Geneva University Hospitals (HUG), Switzerland, E-mail: diano.ollo@gmail.com

⁴Department of Internal Medicine Specialties, Infectious Diseases Division, Geneva University Hospitals (HUG), Switzerland, E-mail: diano.ollo@gmail.com

^*Corresponding Author: Gregor John, Department of Internal Medicine Specialties, Infectious Diseases Division, Geneva University Hospitals (HUG), Gabrielle-Perret-Gentil 4, CH-1205 Geneva, Switzerland, Tel: 0041 79 553 43 08 Email: